Burden of Inflammatory Skin Diseases Based on GBD Data: China vs USA.
作者信息
Zou Yulin, Liao Kexin, Traidl Stephan, Buhl Timo
机构信息
Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany; Department of Dermatology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
出版信息
Acta Derm Venereol. 2025 Jun 4;105:adv43753. doi: 10.2340/actadv.v105.43753.
Abstract
摘要
相似文献
1
Burden of Inflammatory Skin Diseases Based on GBD Data: China vs USA.
Acta Derm Venereol. 2025 Jun 4;105:adv43753. doi: 10.2340/actadv.v105.43753.
2
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
3
Discrepancies in neglected tropical diseases burden estimates in China: comparative study of real-world data and Global Burden of Disease 2021 data (2004-2020).
BMJ. 2025 Feb 18;388:e080969. doi: 10.1136/bmj-2024-080969.
4
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017.
JAMA Dermatol. 2020 Aug 1;156(8):874-881. doi: 10.1001/jamadermatol.2020.1573.
5
Stark differences in cancer epidemiological data between GLOBOCAN and GBD: Emphasis on oral cancer and wider implications.
EClinicalMedicine. 2022 Oct 6;54:101673. doi: 10.1016/j.eclinm.2022.101673. eCollection 2022 Dec.
6
Analysis of the epidemiological burden of acne vulgaris in China based on the data of global burden of disease 2019.
Front Med (Lausanne). 2022 Oct 4;9:939584. doi: 10.3389/fmed.2022.939584. eCollection 2022.
7
Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study.
Mol Psychiatry. 2023 Nov;28(11):4823-4830. doi: 10.1038/s41380-023-02228-3. Epub 2023 Sep 8.
8
Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019.
World J Urol. 2023 Dec;41(12):3629-3634. doi: 10.1007/s00345-023-04658-8. Epub 2023 Oct 13.
9
Assessing Global Frailty Scores: Development of a Global Burden of Disease-Frailty Index (GBD-FI).
Int J Environ Res Public Health. 2020 Aug 6;17(16):5695. doi: 10.3390/ijerph17165695.
10
Different Trends in the Incidence and Mortality Rates of Prostate Cancer Between China and the USA: A Joinpoint and Age-Period-Cohort Analysis.
Front Med (Lausanne). 2022 Feb 3;9:824464. doi: 10.3389/fmed.2022.824464. eCollection 2022.
本文引用的文献
1
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
2
The development and application of a two-step surveillance process for Healthy China Initiative based on wide coverage interagency data.
Glob Health Res Policy. 2023 Sep 22;8(1):42. doi: 10.1186/s41256-023-00326-x.
3
Novel insights into atopic dermatitis.
J Allergy Clin Immunol. 2023 May;151(5):1145-1154. doi: 10.1016/j.jaci.2022.10.023. Epub 2022 Nov 22.
4
Psoriasis.
Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6.
5
Atopic Dermatitis.
N Engl J Med. 2021 Mar 25;384(12):1136-1143. doi: 10.1056/NEJMra2023911.
6
An R package for an integrated evaluation of statistical approaches to cancer incidence projection.
BMC Med Res Methodol. 2020 Oct 15;20(1):257. doi: 10.1186/s12874-020-01133-5.
Zotero 插件